Join our daily newsletter At The Bell to receive exclusive market insights
- LBT Innovations (LBT) has entered a trading halt as it looks to announce a capital raise
- In a statement to the ASX, the meditech company said the capital raised will be used on expanded sales activities in Europe
- This links to LBT’s recent announcement about an agreement with Beckman Coulter to market its APAS Independence technology in the region
- However, the exact details of the capital raise are yet to be released
- Shares in LBT remain in a trading halt, and last traded for 19 cents each
Meditech company LBT Innovations (LBT) is ramping up to announce a capital raise after requesting its shares be placed in a trading halt on the ASX.
While the exact details of the capital raise are yet to be announced, the company stated the money would go towards expanding sales activities of its APAS Independence technology in Europe.
LBT announced this morning it had signed an agreement with marketing agent Beckman Coulter to market the technology in the United Kingdom, France and Germany.
In the meantime, the company has indicated the announcement of the capital raise will be released in coming days, with the trading halt to be lifted no later than July 9, 2020.
Shares in LBT were last trading for 19 cents per share on July 6, 2020, before being placed in the trading halt.
